|
|||||
|
|
| 胰岛素增敏剂的研究进展与应用 | |
| 引用本文： | 张石革,马国辉. 胰岛素增敏剂的研究进展与应用[J]. 中国药业, 2003, 12(9): 21-23 |
| 作者姓名： | 张石革 马国辉 |
| 作者单位： | 北京大学积水潭医院,北京,100035 |
| 摘 要： | 目的：综述胰岛素增敏剂的研究进展和临床应用概况，借以评价其疗效与安全性。方法：采用国内外献进行分析与评价。结果与结尊：胰岛素增敏剂的研制、应用进展迅速，可增强2型糖尿病患对胰岛素的敏感性，改善对血糖和血脂的控制，为临床治疗2型糖尿病开辟了一个重要的和新的途径。 |
| 关 键 词： | 2型糖尿病 噻唑烷二酮类药物 胰岛素增敏剂 靶器官 |
| 文章编号： | 1006-4931(2003)09-0021-02 |
| 修稿时间： | 2003-06-09 |
Review on Progress and Clinical Usage of the Insulin Sensitizer--A New Way of Antidiabetes |
|
| Zhang Shige,Ma Guohui. Review on Progress and Clinical Usage of the Insulin Sensitizer--A New Way of Antidiabetes[J]. China Pharmaceuticals, 2003, 12(9): 21-23 | |
| Authors: | Zhang Shige Ma Guohui |
| Abstract: | Objective:To summarize the aspect of clinical usage and research progress on insulin sensitizer,and evaluate their clinical efficacy and safety.Methods:To collecte medical literatures in recent years at home and abroad.Results and Conclusion:Advance in preparation and clinical usage of insulin sensitizer has been swiftly in recent years,strenthening patients with non-insulin dependent diabetes mellitus susceptibility to insulin,improving the control for blood sugar and hyperlipemia,so insulin sensitizer plays an important part and is a new way in the treatment of diabets. |
| Keywords: | Non-insulin Dependent Diabetes Mellitus Thiazolidinedione Derivatives Insulin Sensitizer Target Organ |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |